chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse drug reaction, Headache, Myalgia, Pyrexia, Vomiting
Clinical narrative: Extremely exaggerated symptoms; 103 degrees F fever since 3 days; vomiting; muscle ache; headache; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE DRUG REACTION (Extremely exaggerated symptoms), PYREXIA (103 degrees F fever since 3 days), VOMITING (vomiting), MYALGIA (muscle ache) and HEADACHE (headache) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. ERH732) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Apr-2021, the patient experienced ADVERSE DRUG REACTION (Extremely exaggerated symptoms), PYREXIA (103 degrees F fever since 3 days), VOMITING (vomiting), MYALGIA (muscle ache) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 21-Apr-2021, VOMITING (vomiting), MYALGIA (muscle ache) and HEADACHE (headache) had resolved. At the time of the report, ADVERSE DRUG REACTION (Extremely exaggerated symptoms) and PYREXIA (103 degrees F fever since 3 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.   This case was linked to MOD-2021-276166 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Follow-up document was  received and had significant information. Updated the outcome of the events( from unknown to recovered).
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Cough, Head discomfort, Nasal congestion, Sinusitis
Clinical narrative: little congestion: heavy chest & head / nasal congestion and a minor cough; little congestion: heavy chest & head / nasal congestion and a minor cough; little congestion: heavy chest & head / nasal congestion and a minor cough; Sinus infection; little congestion: heavy chest & head / nasal congestion and a minor cough; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (little congestion: heavy chest & head / nasal congestion and a minor cough), HEAD DISCOMFORT (little congestion: heavy chest & head / nasal congestion and a minor cough), NASAL CONGESTION (little congestion: heavy chest & head / nasal congestion and a minor cough), COUGH (little congestion: heavy chest & head / nasal congestion and a minor cough) and SINUSITIS (Sinus infection) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 028A21A) for COVID-19 vaccination.     Concomitant products included FUROSEMIDE, CARVEDILOL, LOSARTAN, ATORVASTATIN, ACETYLSALICYLIC ACID (BABY ASPIRIN), NAPROXEN SODIUM, LANSOPRAZOLE (PREVACID), FISH OIL, VITAMIN E NOS, UBIDECARENONE (COQ10 [UBIDECARENONE]), LYSINE HYDROCHLORIDE (L-LYSINE [LYSINE HYDROCHLORIDE]), MAGNESIUM, CALCIUM, ZINC and VITAMIN D2 for an unknown indication.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced CHEST DISCOMFORT (little congestion: heavy chest & head / nasal congestion and a minor cough). On an unknown date, the patient experienced HEAD DISCOMFORT (little congestion: heavy chest & head / nasal congestion and a minor cough), NASAL CONGESTION (little congestion: heavy chest & head / nasal congestion and a minor cough), COUGH (little congestion: heavy chest & head / nasal congestion and a minor cough) and SINUSITIS (Sinus infection). At the time of the report, CHEST DISCOMFORT (little congestion: heavy chest & head / nasal congestion and a minor cough), HEAD DISCOMFORT (little congestion: heavy chest & head / nasal congestion and a minor cough), NASAL CONGESTION (little congestion: heavy chest & head / nasal congestion and a minor cough), COUGH (little congestion: heavy chest & head / nasal congestion and a minor cough) and SINUSITIS (Sinus infection) outcome was unknown. Not Provided          This case was linked to MOD-2021-083389 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: No specific follow-up information recorded.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Insomnia, Neck pain, Pain
Clinical narrative: neck pain; shoulder pain; she also rolls in her sleep on her arms.; soreness that she experienced after receiving her first dose; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (neck pain), ARTHRALGIA (shoulder pain), INSOMNIA (she also rolls in her sleep on her arms.) and PAIN (soreness that she experienced after receiving her first dose) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045A21A and 044B21A,) for COVID-19 vaccination.     Concomitant products included VENLAFAXINE HYDROCHLORIDE (EFFEXOR) and MIRTAZAPINE for Depression, IBUPROFEN for Muscle soreness.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 19-Mar-2021, the patient experienced NECK PAIN (neck pain), ARTHRALGIA (shoulder pain), INSOMNIA (she also rolls in her sleep on her arms.) and PAIN (soreness that she experienced after receiving her first dose). At the time of the report, NECK PAIN (neck pain), ARTHRALGIA (shoulder pain), INSOMNIA (she also rolls in her sleep on her arms.) and PAIN (soreness that she experienced after receiving her first dose) was resolving. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   treatment medication involves Tylenol 500mg (2 tabs) after receiving 2nd dose of Moderna COVID-19 Vaccine. Ibuprofen prior to receiving 2nd dose of Moderna COVID-19 Vaccine other concomitant medication involves vitamins as supplements   This case was linked to MOD-2021-083416 (Patient Link).
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy from head to toe) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced PRURITUS (itchy from head to toe). At the time of the report, PRURITUS (itchy from head to toe) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided. Treatment information was not provided. Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Significant Follow up received on 21-4-2021, patient information added, drug information added.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Head discomfort, Headache, Influenza like illness, Myalgia
Clinical narrative: it is like a cold he can not get rid off; Chest congestion; sore throat; head congestion; flu like symptoms; headache that were coming and going.; muscle soreness; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (muscle soreness), HEADACHE, HEAD DISCOMFORT, INFLUENZA LIKE ILLNESS, and OROPHARYNGEAL PAIN (sore throat) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced MYALGIA (muscle soreness). On 03-Apr-2021, the patient experienced HEADACHE. On 05-Apr-2021, the patient experienced HEAD DISCOMFORT/CONGESTION and INFLUENZA LIKE ILLNESS. On 06-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat). On 07-Apr-2021, the patient experienced CHEST DISCOMFORT/ CONGESTION. On an unknown date, the patient experienced NASOPHARYNGITIS (it is like a cold he can not get rid off). The patient was treated with FUROSEMIDE at a dose of 40 mg four times per day; CARVEDILOL at a dose of 3.125 mg twice a day; LOSARTAN at a dose of 50 mg four times per day; ATORVASTATIN at a dose of 40 mg four times per day; BABY ASPIRIN at an unspecified dose and frequency; NAPROXEN SODIUM at a dose of 500 mg once a day; LANSOPRAZOLE at a dose of 20 mg four times per day; FISH OIL at an unspecified dose and frequency; VITAMIN E at an unspecified dose and frequency; MAGNESIUM at an unspecified dose and frequency; CALCIUM at an unspecified dose and frequency; ZINC at an unspecified dose and frequency and VITAMIN D2 at an unspecified dose and frequency. On 02-Apr-2021, MYALGIA (muscle soreness) outcome was unknown. At the time of the report, HEADACHE, HEAD DISCOMFORT/ CONGESTION, INFLUENZA LIKE ILLNESS, OROPHARYNGEAL PAIN (sore throat), CHEST DISCOMFORT/ CONGESTION and NASOPHARYNGITIS (it is like a cold he can not get rid off) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       This case was linked to MOD-2021-083383 (Patient Link).   Most recent FOLLOW-UP information incorporated above included, On 22-Jul-2021 No significant follow up information received regarding the 1st dose
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Nasopharyngitis, Oropharyngeal pain
Clinical narrative: it is like a cold he can not get rid off; Chest congestion; sore throat; head congestion; flu like symptoms; headache that were coming and going.; muscle soreness; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (muscle soreness), HEADACHE, HEAD DISCOMFORT, INFLUENZA LIKE ILLNESS, and OROPHARYNGEAL PAIN (sore throat) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced MYALGIA (muscle soreness). On 03-Apr-2021, the patient experienced HEADACHE. On 05-Apr-2021, the patient experienced HEAD DISCOMFORT/CONGESTION and INFLUENZA LIKE ILLNESS. On 06-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat). On 07-Apr-2021, the patient experienced CHEST DISCOMFORT/ CONGESTION. On an unknown date, the patient experienced NASOPHARYNGITIS (it is like a cold he can not get rid off). The patient was treated with FUROSEMIDE at a dose of 40 mg four times per day; CARVEDILOL at a dose of 3.125 mg twice a day; LOSARTAN at a dose of 50 mg four times per day; ATORVASTATIN at a dose of 40 mg four times per day; BABY ASPIRIN at an unspecified dose and frequency; NAPROXEN SODIUM at a dose of 500 mg once a day; LANSOPRAZOLE at a dose of 20 mg four times per day; FISH OIL at an unspecified dose and frequency; VITAMIN E at an unspecified dose and frequency; MAGNESIUM at an unspecified dose and frequency; CALCIUM at an unspecified dose and frequency; ZINC at an unspecified dose and frequency and VITAMIN D2 at an unspecified dose and frequency. On 02-Apr-2021, MYALGIA (muscle soreness) outcome was unknown. At the time of the report, HEADACHE, HEAD DISCOMFORT/ CONGESTION, INFLUENZA LIKE ILLNESS, OROPHARYNGEAL PAIN (sore throat), CHEST DISCOMFORT/ CONGESTION and NASOPHARYNGITIS (it is like a cold he can not get rid off) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       This case was linked to MOD-2021-083383 (Patient Link).   Most recent FOLLOW-UP information incorporated above included, On 22-Jul-2021 No significant follow up information received regarding the 1st dose
Sex: M
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Diarrhoea, Exposure to SARS-CoV-2, Headache
Clinical narrative: chills; headache; nausea; vomiting; diarrhea; throwing up all night; eaten little; felt like exposed to COVID; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), HEADACHE (headache), NAUSEA (nausea), VOMITING (vomiting) and DIARRHOEA (diarrhea) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Gastro-intestinal disorder NOS.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced CHILLS (chills), HEADACHE (headache), NAUSEA (nausea), VOMITING (vomiting), DIARRHOEA (diarrhea), VOMITING (throwing up all night), DECREASED APPETITE (eaten little) and EXPOSURE TO SARS-COV-2 (felt like exposed to COVID). At the time of the report, CHILLS (chills), HEADACHE (headache), NAUSEA (nausea), VOMITING (vomiting), DIARRHOEA (diarrhea), VOMITING (throwing up all night), DECREASED APPETITE (eaten little) and EXPOSURE TO SARS-COV-2 (felt like exposed to COVID) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: chills; headache; nausea; vomiting; diarrhea; throwing up all night; eaten little; felt like exposed to COVID; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), HEADACHE (headache), NAUSEA (nausea), VOMITING (vomiting) and DIARRHOEA (diarrhea) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Gastro-intestinal disorder NOS.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Apr-2021, the patient experienced CHILLS (chills), HEADACHE (headache), NAUSEA (nausea), VOMITING (vomiting), DIARRHOEA (diarrhea), VOMITING (throwing up all night), DECREASED APPETITE (eaten little) and EXPOSURE TO SARS-COV-2 (felt like exposed to COVID). At the time of the report, CHILLS (chills), HEADACHE (headache), NAUSEA (nausea), VOMITING (vomiting), DIARRHOEA (diarrhea), VOMITING (throwing up all night), DECREASED APPETITE (eaten little) and EXPOSURE TO SARS-COV-2 (felt like exposed to COVID) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Rash pruritic, Somnolence, Vomiting
Clinical narrative: sleeping; itchy rash on arm; dizzy; vomiting; chills; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (sleeping), RASH PRURITIC (itchy rash on arm), DIZZINESS (dizzy), VOMITING (vomiting) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (sleeping), RASH PRURITIC (itchy rash on arm), DIZZINESS (dizzy), VOMITING (vomiting) and CHILLS (chills). At the time of the report, SOMNOLENCE (sleeping), RASH PRURITIC (itchy rash on arm), DIZZINESS (dizzy), VOMITING (vomiting) and CHILLS (chills) outcome was unknown.            Treatment medication included Tylenol.   This case was linked to MODERNATX, INC.-MOD-2021-083363 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  MODERNATX, INC.-MOD-2021-083363:First dose case
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Myalgia
Clinical narrative: Weakness in one leg; Muscle soreness; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (Weakness in one leg) and MYALGIA (Muscle soreness) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     Concurrent medical conditions included Sciatic nerve lesion NOS (in one leg). Concomitant products included VITAMIN D [VITAMIN D NOS], ZINC and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced MUSCULAR WEAKNESS (Weakness in one leg) and MYALGIA (Muscle soreness). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of 1 dosage form. On 19-Apr-2021, MUSCULAR WEAKNESS (Weakness in one leg) and MYALGIA (Muscle soreness) had resolved.            Patient reported that she experienced weakness in leg in which she had sciatic issues. Patient received 2nd vaccine on either 28 Apr 2021 or  29 Apr 2021 with no AEs at all. Patient had nothing further to report.   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Significant follow up received: second dose information added and action taken with suspect product was updated accordingly.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal, Peripheral coldness
Clinical narrative: Dizzy; Weird sensation; Cold feet; This spontaneous case was reported by a patient and describes the occurrence of DIZZINESS (Dizzy), FEELING ABNORMAL (Weird sensation) and PERIPHERAL COLDNESS (Cold feet) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizzy), FEELING ABNORMAL (Weird sensation) and PERIPHERAL COLDNESS (Cold feet). At the time of the report, DIZZINESS (Dizzy), FEELING ABNORMAL (Weird sensation) and PERIPHERAL COLDNESS (Cold feet) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications  reported were Vitamin C and estroben. No treatment medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Feeling feverish; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Feeling feverish) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history information was reported.     On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Feeling feverish). At the time of the report, PYREXIA (Feeling feverish) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Influenza like illness
Clinical narrative: Flu-like symtoms; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symtoms) and FATIGUE (Tiredness) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symtoms) and FATIGUE (Tiredness). On 01-Mar-2021, INFLUENZA LIKE ILLNESS (Flu-like symtoms) and FATIGUE (Tiredness) had resolved. Not Provided          Concomitant medication use was not provided. Treatment information was not provided.   This case was linked to MOD-2021-093357 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Follow up document received on 4-AUG-2021 contains Non-Significant information.
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: second dose administered two months after the first dose; This spontaneous case was reported by a health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose administered two months after the first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose administered two months after the first dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose administered two months after the first dose) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information provided.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Malaise, Pain, Pyrexia, Tremor
Clinical narrative: Body aches; Shakes; Vomiting whatever she is eating; Fever; Not able to sleep since last night; It has been more than 24 hours; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), INSOMNIA (not able to sleep since last night), VOMITING (vomiting whatever she is eating), PAIN (body aches) and TREMOR (shakes) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003821A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced PYREXIA (fever), INSOMNIA (not able to sleep since last night), VOMITING (vomiting whatever she is eating), PAIN (body aches), TREMOR (shakes) and MALAISE (it has been more than 24 hours). At the time of the report, PYREXIA (fever), INSOMNIA (not able to sleep since last night), VOMITING (vomiting whatever she is eating), PAIN (body aches), TREMOR (shakes) and MALAISE (it has been more than 24 hours) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD21-079970 (Patient Link).
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Body aches; Shakes; Vomiting whatever she is eating; Fever; Not able to sleep since last night; It has been more than 24 hours; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), INSOMNIA (not able to sleep since last night), VOMITING (vomiting whatever she is eating), PAIN (body aches) and TREMOR (shakes) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003821A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced PYREXIA (fever), INSOMNIA (not able to sleep since last night), VOMITING (vomiting whatever she is eating), PAIN (body aches), TREMOR (shakes) and MALAISE (it has been more than 24 hours). At the time of the report, PYREXIA (fever), INSOMNIA (not able to sleep since last night), VOMITING (vomiting whatever she is eating), PAIN (body aches), TREMOR (shakes) and MALAISE (it has been more than 24 hours) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD21-079970 (Patient Link).
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Arm was sore; Fever every day; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was sore) and PYREXIA (Fever every day) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048B21A and 006B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Apr-2021, the patient experienced PYREXIA (Fever every day). On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm was sore). At the time of the report, PAIN IN EXTREMITY (Arm was sore) and PYREXIA (Fever every day) outcome was unknown. Not Provided          Treatment details not reported.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Migraine, Nausea
Clinical narrative: headache; nausea; suffer with migraines; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), NAUSEA (nausea) and MIGRAINE (suffer with migraines) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 278A21A.) for COVID-19 vaccination.     The patient's past medical history included Migraine. Concomitant products included NARATRIPTAN HYDROCHLORIDE (NARATRIPTAN ACTAVIS) for an unknown indication.    On 05-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache), NAUSEA (nausea) and MIGRAINE (suffer with migraines). At the time of the report, HEADACHE (headache), NAUSEA (nausea) and MIGRAINE (suffer with migraines) outcome was unknown. Not Provided
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: soreness; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MYALGIA (soreness) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045A21A and 044B21A) for COVID-19 vaccination.     Concomitant products included VENLAFAXINE HYDROCHLORIDE (EFFEXOR) and MIRTAZAPINE for an unknown indication.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (soreness). At the time of the report, MYALGIA (soreness) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Medical History information was reported.  Vitamins used as a Concomitant medication.  Ibuprofen prior to receiving 2nd dose of Moderna COVID-19 Vaccine.  Tylenol 500mg (2 tabs) after receiving 2nd dose of Moderna COVID-19 Vaccine.   This case was linked to MOD-2021-083384.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Very very sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Very very sore arm ) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 014M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Feb-2021, the patient experienced PAIN IN EXTREMITY (Very very sore arm ). At the time of the report, PAIN IN EXTREMITY (Very very sore arm ) outcome was unknown. Not Provided  :Mother case- dose 1
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Bradycardia, Hypoaesthesia, Palpitations
Clinical narrative: Anxiety; hands and toes and bottom on feet are feeling numb/fingertips felt a little numb/numbness in the right side of face; heart palpitations; low heart rate; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BRADYCARDIA (low heart rate), HYPOAESTHESIA (hands and toes and bottom on feet are feeling numb/fingertips felt a little numb/numbness in the right side of face), PALPITATIONS (heart palpitations) and ANXIETY (Anxiety) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Ventricular septal defect. Concomitant products included LEVOCETIRIZINE DIHYDROCHLORIDE (XYZAL) and FLUTICASONE PROPIONATE for Allergy.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, the patient experienced BRADYCARDIA (low heart rate) and PALPITATIONS (heart palpitations). On 20-Apr-2021, the patient experienced HYPOAESTHESIA (hands and toes and bottom on feet are feeling numb/fingertips felt a little numb/numbness in the right side of face). On an unknown date, the patient experienced ANXIETY (Anxiety). At the time of the report, BRADYCARDIA (low heart rate), HYPOAESTHESIA (hands and toes and bottom on feet are feeling numb/fingertips felt a little numb/numbness in the right side of face), PALPITATIONS (heart palpitations) and ANXIETY (Anxiety) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information not provided.  Company comment: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Pharmacist gave a patient a second dose at 20 days instead of 28 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Pharmacist at the Walmart gave a patient a second dose at 20 days instead of 28 days). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Pharmacist gave a patient a second dose at 20 days instead of 28 days) had resolved. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. NO CONCOMINANT AND TREATMENT DRUGS WERE USED. Patient doesn't have any complication from vaccine. Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: Follow-up received on 21-may 2021: added to narrative and event outcome changed to recovered.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site urticaria
Clinical narrative: Wealth formed; Itching at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching at the injection site) and VACCINATION SITE URTICARIA (Welt formed) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection site). On 21-Apr-2021, the patient experienced VACCINATION SITE URTICARIA (Welt formed) and had extreme itchiness at injection site. At the time of the report, VACCINATION SITE PRURITUS (Itching at the injection site) and VACCINATION SITE URTICARIA (Welt formed) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Decreased appetite, Erythema, Feeling hot
Clinical narrative: not much of an apatite; hot flashes; fever of 100.5 degrees; very bad chills; body aches; cheeks were red and hot to touch; cheeks were red and hot to touch; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), FEELING HOT (cheeks were red and hot to touch), ERYTHEMA (cheeks were red and hot to touch), DECREASED APPETITE (not much of an apatite) and HOT FLUSH (hot flashes) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced PAIN (body aches), FEELING HOT (cheeks were red and hot to touch), ERYTHEMA (cheeks were red and hot to touch), PYREXIA (fever of 100.5 degrees) and CHILLS (very bad chills). On 21-Apr-2021, the patient experienced DECREASED APPETITE (not much of an apatite) and HOT FLUSH (hot flashes). On 21-Apr-2021, PAIN (body aches), FEELING HOT (cheeks were red and hot to touch), ERYTHEMA (cheeks were red and hot to touch), PYREXIA (fever of 100.5 degrees) and CHILLS (very bad chills) had resolved. At the time of the report, DECREASED APPETITE (not much of an apatite) and HOT FLUSH (hot flashes) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Apr-2021, Body temperature: 100.5 (High) fever of 100.5 degrees.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter.  Treatment details included that the patient took paracetamol for every four hours.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Hot flush, Pain, Pyrexia
Clinical narrative: not much of an apatite; hot flashes; fever of 100.5 degrees; very bad chills; body aches; cheeks were red and hot to touch; cheeks were red and hot to touch; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), FEELING HOT (cheeks were red and hot to touch), ERYTHEMA (cheeks were red and hot to touch), DECREASED APPETITE (not much of an apatite) and HOT FLUSH (hot flashes) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced PAIN (body aches), FEELING HOT (cheeks were red and hot to touch), ERYTHEMA (cheeks were red and hot to touch), PYREXIA (fever of 100.5 degrees) and CHILLS (very bad chills). On 21-Apr-2021, the patient experienced DECREASED APPETITE (not much of an apatite) and HOT FLUSH (hot flashes). On 21-Apr-2021, PAIN (body aches), FEELING HOT (cheeks were red and hot to touch), ERYTHEMA (cheeks were red and hot to touch), PYREXIA (fever of 100.5 degrees) and CHILLS (very bad chills) had resolved. At the time of the report, DECREASED APPETITE (not much of an apatite) and HOT FLUSH (hot flashes) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Apr-2021, Body temperature: 100.5 (High) fever of 100.5 degrees.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter.  Treatment details included that the patient took paracetamol for every four hours.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Vertigo
Clinical narrative: Vertigo/patient continues to experience mild vertigo; greater than 35 days between Moderna Covid-19 vaccines; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 21-Apr-2021 and was forwarded to Moderna on 21-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo/patient continues to experience mild vertigo) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (greater than 35 days between Moderna Covid-19 vaccines) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 044B2114) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Jul-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (greater than 35 days between Moderna Covid-19 vaccines). On an unknown date, the patient experienced VERTIGO (Vertigo/patient continues to experience mild vertigo). At the time of the report, VERTIGO (Vertigo/patient continues to experience mild vertigo) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (greater than 35 days between Moderna Covid-19 vaccines) outcome was unknown. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product information was not provided Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 03-Aug-2021: In follow-up information, reporter contact detail, 2nd dose detail ( vaccination  date, 2nd dose Batch number, Vaccine information), Facility Type were Updated . Event of "Inappropriate schedule of vaccine administered" was added .
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE PAIN (pain) and PERIPHERAL SWELLING (Swelling under the arm) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On an unknown date, the patient experienced VACCINATION SITE PAIN (pain) and PERIPHERAL SWELLING (Swelling under the arm). At the time of the report, VACCINATION SITE PAIN (pain) and PERIPHERAL SWELLING (Swelling under the arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments. Reporter did not allow further contact.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blood test, Chills, Mobility decreased, Restlessness
Clinical narrative: Limiting effect on mobility; Pain in ankle/ leg pain; Chills; Restless/tired; This spontaneous case was reported by a consumer and describes the occurrence of RESTLESSNESS (Restless/tired), MOBILITY DECREASED (Limiting effect on mobility), ARTHRALGIA (Pain in ankle/ leg pain) and CHILLS (Chills) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031B21A and 022M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID], CALCIUM CARBONATE (CALTRATE [CALCIUM CARBONATE]), ATORVASTATIN CALCIUM (LIPITOR), LEVOTHYROXINE, METOPROLOL and HCTZ for an unknown indication.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced RESTLESSNESS (Restless/tired) and CHILLS (Chills). On 20-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MOBILITY DECREASED (Limiting effect on mobility) and ARTHRALGIA (Pain in ankle/ leg pain). The patient was treated with VITAMIN B6 at a dose of 1 dosage form and CYANOCOBALAMIN, FOLIC ACID (VITAMIN B12 & FOLIC ACID) ongoing since an unknown date at a dose of 1 dosage form. On 12-Apr-2021, CHILLS (Chills) had resolved. On 15-Apr-2021, RESTLESSNESS (Restless/tired) had resolved. At the time of the report, MOBILITY DECREASED (Limiting effect on mobility) outcome was unknown and ARTHRALGIA (Pain in ankle/ leg pain) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Apr-2021, Blood test: negative (Negative) Performed a blood clot test which returned negative.         Treatment information included Vitamins prescribed by neurologist.  Patient was referred to a neurologist who also performed a number a tests, with all returning negative. Patient stated neurologist began her on a vitamin regimen, but she has not seen any relief so far.  Patient said that she went to the doctor and gave her vitamin B6 , B12 and folic acid to take. She said her legs are doing better. Dr. said she may need physical therapy.   Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: Follow up information was received on 8 May 2021: updated event - Mobility decreased, added the outcome of the event leg pain as not recovered, added lab test and concomitant medication. Patient had been to her Primary Physician and Neurologist. On 03-Aug-2021: Follow-up information received contains updated outcome of the event leg pain as recovering, updated concomitant medications
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Injection site pain, Neck pain
Clinical narrative: injection arm soreness; chills; neck pain; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (injection arm soreness), CHILLS (chills) and NECK PAIN (neck pain) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ATORVASTATIN for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced INJECTION SITE PAIN (injection arm soreness), CHILLS (chills) and NECK PAIN (neck pain). At the time of the report, INJECTION SITE PAIN (injection arm soreness), CHILLS (chills) and NECK PAIN (neck pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: arm muscle was sore; fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (arm muscle was sore) and PYREXIA (fever) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045A21A and 037B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Mar-2021, the patient experienced MYALGIA (arm muscle was sore) and PYREXIA (fever). On 23-Mar-2021, MYALGIA (arm muscle was sore) and PYREXIA (fever) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided. Treatment includes Tramadol.   This case was linked to US-MODERNATX, INC.-MOD-2021-083468 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-083468:Case for dose 2
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Neck pain
Clinical narrative: extreme fatigue like really bad; headache; achiness across my shoulder and neck basically the whole area; extremely exhausted for 4 days; achiness across my shoulder and neck basically the whole area; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (extreme fatigue like really bad), HEADACHE (headache), ARTHRALGIA (achiness across my shoulder and neck basically the whole area), FATIGUE (extremely exhausted for 4 days) and NECK PAIN (achiness across my shoulder and neck basically the whole area) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 032L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 11-Mar-2021, the patient experienced FATIGUE (extreme fatigue like really bad), HEADACHE (headache), ARTHRALGIA (achiness across my shoulder and neck basically the whole area), FATIGUE (extremely exhausted for 4 days) and NECK PAIN (achiness across my shoulder and neck basically the whole area). At the time of the report, FATIGUE (extreme fatigue like really bad), HEADACHE (headache), ARTHRALGIA (achiness across my shoulder and neck basically the whole area), FATIGUE (extremely exhausted for 4 days) and NECK PAIN (achiness across my shoulder and neck basically the whole area) outcome was unknown. Not Provided      This case was linked to MOD-2021-083418 (Patient Link).; Sender's Comments:  Mother case- dose 2